Name: 2-(pyridin-2-yl)-n-(5-{4-[6-({[3-(trifluoromethoxy)phenyl]acetyl}amino)pyridazin-3-yl]butyl}-1,3,4-thiadiazol-2-yl)acetamide |
Formula: C26 H24 F3 N7 O3 S |
Weight: 571.574 |
SMILES: "FC(F)(F)Oc1cccc(CC(=O)Nc2ccc(CCCCc3sc(NC(=O)Cc4ccccn4)nn3)nn2)c1" |
Spacial conformation based on PDB
?. Also present on 5hl1, 5jyo |
RESIDUE 63J 64 CONECT C10 4 C09 C11 H1 H2 CONECT C13 3 C12 C14 H3 CONECT C15 3 C14 N16 H4 CONECT C20 3 C21 C19 N40 CONECT C21 3 C20 C22 H5 CONECT C22 3 C21 C23 H6 CONECT C26 4 C25 C27 H7 H8 CONECT C28 3 C27 C29 H9 CONECT C01 4 C02 C19 H10 H11 CONECT C02 4 C01 C03 H12 H13 CONECT C03 4 C02 C04 H14 H15 CONECT C04 3 C03 N05 S18 CONECT N05 2 C04 N06 CONECT N06 2 N05 C07 CONECT C07 3 N06 N08 S18 CONECT N08 3 C07 C09 H16 CONECT C09 3 C10 N08 O17 CONECT C11 3 C10 C12 N16 CONECT C12 3 C13 C11 H17 CONECT C14 3 C13 C15 H18 CONECT N16 2 C15 C11 CONECT O17 1 C09 CONECT S18 2 C04 C07 CONECT C19 4 C20 C01 H19 H20 CONECT C23 3 C22 N24 N39 CONECT N24 3 C23 C25 H21 CONECT C25 3 C26 N24 O38 CONECT C27 3 C26 C28 C32 CONECT C29 3 C28 C30 H22 CONECT C30 3 C29 C31 H23 CONECT C31 3 C30 C32 O33 CONECT C32 3 C27 C31 H24 CONECT O33 2 C31 C34 CONECT C34 4 O33 F35 F36 F37 CONECT F35 1 C34 CONECT F36 1 C34 CONECT F37 1 C34 CONECT O38 1 C25 CONECT N39 2 C23 N40 CONECT N40 2 C20 N39 CONECT H1 1 C10 CONECT H2 1 C10 CONECT H3 1 C13 CONECT H4 1 C15 CONECT H5 1 C21 CONECT H6 1 C22 CONECT H7 1 C26 CONECT H8 1 C26 CONECT H9 1 C28 CONECT H10 1 C01 CONECT H11 1 C01 CONECT H12 1 C02 CONECT H13 1 C02 CONECT H14 1 C03 CONECT H15 1 C03 CONECT H16 1 N08 CONECT H17 1 C12 CONECT H18 1 C14 CONECT H19 1 C19 CONECT H20 1 C19 CONECT H21 1 N24 CONECT H22 1 C29 CONECT H23 1 C30 CONECT H24 1 C32 END HET 63J 64 HETNAM 63J 2-(pyridin-2-yl)-N-(5-{4-[6-({[3-(trifluoromethoxy)phen HETNAM 2 63J yl]acetyl}amino)pyridazin-3-yl]butyl}-1,3,4-thiadiazol- HETNAM 3 63J 2-yl)acetamide FORMUL 63J C26 H24 F3 N7 O3 S1
This OCA
MONOMER page uses Jmol, developed by the Jmol Development Team (color reference)
|